Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer Baidu BIDU Market Conditions Baidu posts 126 EPS beat fueled by robust AI segment growth US First Amendment Defamation Lawsuit Dismissal Implications for Media Entities and Public Figure Litigation Risk CINF Cincy Fin posts 143 percent Q4 2025 EPS beat yet shares slide 22 percent in todays trading session NESR National delivers 235 percent Q4 2025 EPS beat shares gain 347 percent on positive investor sentiment